Skip to main content
. 2022 Nov 29;10(12):2039. doi: 10.3390/vaccines10122039

Figure 2.

Figure 2

Timeline of the Development of BNT162b2 [46,47,51,52,53,54,55,56,57]. CMA, conditional marketing authorization; EUA, emergency use authorization.